Laboratorios Rovi : Share price weakness provides a buying opportunity
>Contamination issues at Rovi plants seem confined to a limited number of vaccine batches in Japan and do not seem to compromise safety - Yesterday, Laboratorios Rovi shares were down on the news that foreign matter was found in new batches of Moderna vaccines in Japan in the Okinawa and Gunma prefectures. Laboratorios Rovi also signalled a relevant fact on Sunday when saying that there is no evidence to-date that the death of two individuals who had received the Mode...Laboratorios Farmaceuticos Rovi is engaged in the sale of its own pharmaceutical products and the distribution of other products for which it holds licenses granted by other laboratories for specific periods, in accordance with the terms and conditions contained in the agreements entered into with said laboratories.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.